PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

